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Abstract Loss of dopaminergic neurons in the substantia
nigra pars compacta and the resulting decrease in striatal
dopamine levels are the hallmarks of Parkinson’s disease.
Tgfb and Gdnf have been identiﬁed as neurotrophic factors
for dopaminergic midbrain neurons in vivo and in vitro.
Haploinsufﬁciency for either Tgfb or Gdnf led to dopami-
nergic deﬁcits. In this study we therefore analyzed the
nigrostriatal system of aged Tgfb2
?/-/Gdnf
?/- double-
heterozygous mice. Unexpectedly, we found no morpho-
logical changes in the nigrostriatal system as compared
with age-matched wild-type mice. There were no signiﬁ-
cant differences in the number of TH-positive midbrain
neurons and no changes in the optical density of TH
immunoreactivity in striata of Tgfb2
?/-/Gdnf
?/- double-
heterozygous mice. Moreover, we found no signiﬁcant
differences in the striatal levels of dopamine and its
metabolites dihydroxyphenylacetic acid and homovanillic
acid. Our results indicate that a combined haploinsufﬁ-
ciency for Tgfb2 and Gdnf has no impact on the function
and the survival of midbrain DA neurons under normal
aging conditions.
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Introduction
The deleterious loss of dopaminergic (DA) neurons in the
substantia nigra pars compacta (SNpc) and the resulting
decrease in dopamine (DA) levels in the striatum, the main
target projection area of SNpc DA neurons, are the hall-
marks of Parkinson’s disease (PD; Dauer and Przedborski
2003). Although the exact mechanisms for degeneration of
DA neurons in the SNpc have not yet been elucidated,
many in vivo and in vitro attempts have been made to
identify neuroprotective factors. Tgfb and Gdnf have
attracted scientiﬁc attention as they are able to increase the
numbers of cultured midbrain DA neurons (Farkas et al.
2003; Krieglstein et al. 1995; Lin et al. 1993). Moreover,
Tgfb and Gdnf are able to protect DA neurons in different
models of PD, such as 1-methyl-4-phenyl-1,2,3,6-tetrahy-
dropyridine (MPTP) toxicity (Krieglstein and Unsicker
1994; Krieglstein et al. 1995; Tomac et al. 1995; Kordower
et al. 2000) and 6-hydroxydopamine (6-OHDA) toxicity
(Hoffer et al. 1994; Bowenkamp et al. 1995; Kearns and
Gash 1995). Recently, it has been shown that Gdnf requires
the presence of endogenous Tgfb to exert its neuropro-
tective effects on different peripheral and CNS neuron
populations (Krieglstein et al. 1998). Accordingly, Gdnf-
mediated neuroprotection in the MPTP-lesioned nigrostri-
atal system is Tgfb-dependent (Schober et al. 2007). These
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DOI 10.1007/s00702-010-0406-7results suggest a Tgfb/Gdnf synergism, which is further
underlined by the fact that Tgfb increases Gdnf respon-
siveness in neurons by recruiting the Gdnf receptor GFRa1
to the cell membrane (Peterziel et al. 2002).
However, the role of Tgfb and Gdnf for the develop-
ment of midbrain DA neurons and their maintenance under
normal conditions remains elusive. Mice deﬁcient for
either Tgfb2 (Sanford et al. 1997)o rGdnf (Pichel et al.
1996) die perinatally. As a consequence, the nigrostriatal
system can only be investigated prenatally. Interestingly,
the double-deﬁciency of both Tgfb2 and Gdnf does not
affect the differentiation and survival of midbrain DA
neurons during embryonic development (Roussa et al.
2008;S a ´nchez et al. 1996). Tgfb2
-/-/Gdnf
-/- mice
showed no loss of midbrain DA neurons at E14.5 (Roussa
et al. 2008) and E18.5 (Rahhal et al. 2009), indicating that
Tgfb2/Gdnf synergism is not important for the induction of
the dopaminergic phenotype in vivo. In contrast, recent
studies found that Tgfb2
?/- heterozygous mice have 12%
fewer dopaminergic neurons at 6 weeks of age and 30%
less dopamine in the striatum than controls (Andrews et al.
2006). Gdnf
?/- heterozygous mice showed an accelerated
decline of dopaminergic neurons during aging along with
functional deﬁcits (Boger et al. 2006). These studies thus
imply that Tgfb2 and Gdnf might serve as factors regu-
lating the function and the survival of adult midbrain DA
neurons.
In the present study we thus analyzed the nigrostriatal
system of aged Tgfb2
?/-/Gdnf
?/- double-heterozygous
mice. Using tyrosine hydroxylase immunohistochemistry,
we demonstrate that double-heterozygous animals had no
morphological changes in the nigrostriatal system as
compared with age-matched wild-type mice. Moreover, we
found no signiﬁcant differences in the striatal levels of
dopamine (DA) and its metabolites dihydroxyphenylacetic
acid (DOPAC) and homovanillic acid (HVA). Our results
indicate that a combined haploinsufﬁciency for Tgfb2 and
Gdnf, in contrast to the single haploinsufﬁciencies, has no
impact on the function and the survival of midbrain DA
neurons under normal aging conditions.
Materials and methods
Animals
The generation of Tgfb2 and Gdnf single mutant animals
was described previously (Sanford et al. 1997, Pichel et al.
1996). To generate Tgfb2
?/-/Gdnf
?/- animals, single-
heterozygous mice were crossbred. Mice were bred locally
in the Central Animal Facility (University of Go ¨ttingen) on
a C57BL/6 9 129S background. The experimental setup
was approved by the local chief veterinarian. Animals were
housed in cages (1–4 mice per cage) and had ad libitum
access to food and water. Mice were maintained in a 12 h
dark/light cycle with light from 7:00 am to 7:00 pm and a
constant temperature of 20–22C. For experiments carried
out during this study, adult mice with ages ranging from 20
to 25 month were used and are from now on referred to as
aged.
Genomic DNA isolation and genotyping
Genomic DNA was isolated from tail biopsies. Heterozy-
gous Tgfb2 mice were detected by PCR using the exon 6
speciﬁc primers p5 (50-AATGTGCAGGATAATTGCTG-
30) and p3 (50-AACTCCATAGATATGGGCATG-30)a s
described by Sanford et al. (1997). Gdnf heterozygous
animals were detected by PCR using the wild-type allele
speciﬁc primers GdnfF (50-GACTACGGGAGGAGTAGA
AG-30) and GdnfR (50-TATCGTCTCTGCCTTTGTCC-30)
as well as the neomycin cassette speciﬁc primers NEOF
(50-CCAGAGAATTCCAGAGGGAAAGGTC-30)a n dN E O R
(50-CAGATACATCCACACCGTTTAGCGG-30). PCR prod-
ucts were separated by agarose gel electrophoresis and
visualized using ethidium bromide staining (Fig. 1).
RNA isolation and RT-PCR
RNA was isolated from striatal tissue of aged single-het-
erozygous mice using TRIZOL reagent (Invitrogen)
according to the manufacturer’s instructions. 1 lg of each
sample was reverse transcribed using Fermentas Reverse
Aid
TM according to the manufacturer’s instructions.
RT-PCR was performed using the following primers:
Gdnffor 50-GGCCACTTGGAGTTAATGTC-30, Gdnfrev
50-CCGATTCCTCTCTCA TCGAG-30, Tgfb2for 50-GGA
GGTGATTTCCATCTACAA-30, Tgfb2rev 50-GGGAGA
TGTT AAGTCTTTGGA-30. Gapdh was used as loading
control (Gapdhfor 50-TGACCAGGCGCCCAATAC-30,
Fig. 1 Genotyping results for Tgfb2 and Gdnf mutant animals. a A
132-bp fragment of the Tgfb2 wild-type allele and a 1,300-bp
fragment of the NEO-cassette served to determine wt and heterozy-
gous animals. b For the detection of Gdnf
?/- animals a 480-bp
fragment was ampliﬁed from the NEO-cassette in combination with a
338-bp fragment ampliﬁed from the wild-type Gdnf allele
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123Gapdhrev 50-CGGCCGCATCTTCTTGTG-30). After aga-
rose gel electrophoresis and ethidium bromide staining,
images were captured with FluorChem800 (AlphaInnotech,
Biozym). Densitometric analysis was performed with
FlourChem 8800 software (AlphaInnotech, Biozym) and
values were normalized to Gapdh.
Determination of striatal DA and metabolites
Concentrations of dopamine (DA), dihydroxyphenylacetic
acid (DOPAC) and homovanillic acid (HVA) from striatal
tissue samples were analyzed using HPLC with electro-
chemical detection. Brieﬂy, animals were killed by cer-
vical dislocation, brains were rapidly removed and chilled
on ice. Left side striata were dissected, weighed and stored
in homogenator vials containing ceramic pearls. 0.1 M
perchloric acid was added (40 ll/mg tissue) and tissue
samples were stored at -80C until measurements. Prior
to measurements, tissues were homogenized using Ho-
mogenator Precellys24 (PEQLAB, Erlangen, Germany)
with two shakes of 30 s each. Afterwards, all vials were
centrifuged (5 min, 1,000 g,4 C) and 20 ll of supernatant
was loaded onto a reverse-phase column (prontosil 120-3-
C18, Bischoff, Leonberg, Germany). Dopamine was
detected electrochemically using an ESA Coulochem II
detector with a 5011A analytical cell (400 mV). Each liter
of the mobile phase contained 105 ml methanol (MERK)
6.973 g of sodium acetate; 0.048 g of EDTA; 7.355 g of
citric acid mono hydrated; 0.105 g octane sulfonate. pH
4.3 was reached using concentrated citric acid. For each
run, standards of 0.15 or 0.3 or 1.5 lM of dopamine (DA),
dihydroxyphenylacetic acid (DOPAC), and homovanillic
acid (HVA) were measured at the beginning, in the middle
and at the end of the sample sequences. Finally, DA levels
were normalized to wild-type levels and are given in
percentages.
Immunohistochemistry
Brains from animals sacriﬁced for striatal DA analysis
were ﬁxed with 4% paraformaldehyde in 0.1 M phos-
phate overnight and stored in phosphate buffered saline
(PBS; 0.9% NaCl, 0.01 M phosphate buffer) containing
30% sucrose at 4C. Nigral and striatal free-ﬂoating
sections (40 lm) were stained using the PaP-DAB
method. After rinsing with tris-buffered saline (TBS;
0.05 M Tris, 0.9% NaCl) three times for 10 min, sec-
tions were quenched with 3% hydrogen peroxide (H2O2)
for 5 min and rinsed again in TBS three times for
10 min. Sections were incubated for 3 h at room tem-
perature with blocking solution containing 10% normal
goat serum (NGS; Gibco), 0.5% bovine serum albumin
(BSA; Roth, Karlsruhe, Germany). Thereafter, sections
were incubated overnight with rabbit anti-TH polyclonal
antibody (Millipore, AB152) diluted 1:3,000 in blocking
solution at room temperature with gentle shaking. After
rinsing three times with TBS for 10 min, sections were
incubated for 1 h with goat anti-rabbit antibody (Nordic
Immunology) diluted 1:500 in blocking solution gently
shaking at room temperature. Again, sections were rinsed
three times with TBS for 10 min and incubated for 1 h
at room temperature with PaP-rabbit (Nordic Immunol-
ogy) diluted 1:800 in blocking solution. Immunoreactiv-
ity was visualized using diaminobenzidine (Sigma) as
described by Adams (1981). Sections were mounted on
gelatine-coated slides, air-dried overnight, dehydrated
through graded ethanols, cleared in xylene and ﬁnally
coverslipped with Entellan mounting medium (Merck).
Images were taken with Biozero BZ-8000 microscope
(KEYENCE, Germany).
Striatal TH ﬁber density measurements
Striatal TH-positive ﬁber staining was assessed by optical
density (OD) analysis. Images of stained striatal sections
were captured using a NIKON SMZ 1500 (Nikon, Du ¨s-
seldorf, Germany). ODs were measured using AlphaEase
Software (AlphaInnotech, Biozym). For every animal, the
ODs from three different striatal and cortical sections were
determined and the ﬁnal reading was calculated as an
average of the ratio of striatal and cortical TH-staining
from the same section. OD values are expressed as per-
centages of control.
Stereological analysis of TH-positive cells
The number of TH-positive cells of the substantia nigra
pars compacta (SNpc) was assessed using the Stereo-
Investigator (Microbrightﬁeld Europe, Magdeburg, Ger-
many) with optical fractionator according to the optical
dissector rules (Gundersen et al. 1988). The medial ter-
minal nucleus (MTN) of the accessory optical tract was
used as the medial border of the SNpc, as described by
Sauer et al. (1995). For each animal, ﬁve sections with an
evaluation interval of 3 were selected and all TH-positive
neurons lateral to the MTN were counted. The nucleus of
each TH-immunoreactive neuron was chosen as the
counting unit. The optical fractionator was optimized to
reach a coefﬁcient of error B0.1. Cell counts were per-
formed using a 639 oil objective (Zeiss, Go ¨ttingen) and
AxioImager (Zeiss, Go ¨ttingen).
Western blot
Total proteins were isolated from midbrain and stria-
tum samples from 3-month-old Tgfb2
?/?/Tgfb2
?/- and
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?/?/Gdnf
?/- animals using M-PER
Mammalian Protein Extraction Reagent (Pierce) supple-
mented with Complete Protease Inhibitor cocktail (Roche).
10 lg protein was loaded per lane of 9% SDS-polyacryl-
amide gels and separated by electrophoresis. Proteins were
the transferred onto PVDF membranes (Immobilon, Mili-
pore, Schwalbach, Germany). After transfer, the mem-
branes were washed with TBST and blocked with 10% dry
milk (Roth, Karlsruhe, Germany) in TBST for 2 h at room
temperature. Membranes were incubated with primary
antibodies (anti-Tgfb2, SantaCruz, 1:200; anti-Gdnf, R&D
Systems, 1:1,000) at 4C overnight with gently shaking.
After incubation with horseradish peroxidase-conjugated
secondary antibodies (GaR-HRP/GaM-HRP, Cell Signal-
ing Technology, 1:10,000), labeled proteins were detected
using the SuperSignal
TM detection Kit (Pierce, USA). To
conﬁrm equal protein loadings, membranes were reprobed
with a Gapdh antibody (1:10,000, Abcam). All blots were
captured with Amersham Hyperﬁlm
TM ECL (GE Health-
care). Densitometric analysis was performed using Fluor-
Chem 8800 software (AlphaInnotech, Biozym, Olendorf,
Germany).
Statistics
Statistical analysis was performed using the software
GraphPad Prim 4 (GraphPad Software Inc.). For determi-
nation of signiﬁcant differences the unpaired t test or one-
way ANOVA and Bonferroni’s post hoc test for multiple
comparisons was used. P values\0.05 were considered to
be signiﬁcant.
Results
Reduced mRNA levels of Tgfb2 and Gdnf
in heterozygous animals
To learn more about the role of Tgfb2 and Gdnf for the
survival of dopaminergic neurons, we used their combined
deﬁciency in Tgfb2
?/-/Gdnf
?/- double-heterozygous
mice. For the interpretation of our ﬁndings it is important
to know the extent of Tgfb2/Gdnf deﬁciency in these ani-
mals. We therefore determined the expression levels of
Tgfb2 and Gdnf by semiquantitative RT-PCR. To deter-
mine the mRNA levels of Tgfb2 and Gdnf in the dopami-
nergic system of heterozygous animals, aged mice were
killed and total RNA was isolated from striatum. As shown
in Fig. 2a the levels of Tgfb2 mRNA in heterozygous mice
were signiﬁcantly reduced compared to age-matched wild-
type littermates. Figure 2b shows the corresponding results
for Gdnf RNA levels. Again, the levels of Gdnf RNA were
signiﬁcantly reduced in heterozygous animals.
Reduced protein levels of Tgfb2 and Gdnf
in heterozygous mice
After we have shown that the mRNA levels of Tgfb2 and
Gdnf were reduced in heterozygous mice we further ana-
lyzed if the corresponding protein levels were also reduced.
As shown in Fig. 3 protein levels of Tgfb2 were reduced in
midbrain (Fig. 3a, c) and striatum (Fig. 3d, f) samples from
Tgfb2 heterozygous mice. Interestingly, we observed
increased protein levels of Gdnf in striatal samples from
Tgfb2 heterozygous mice (Fig. 3e, f), whereas the levels of
Gdnf in midbrain samples were similar to wild-type lit-
termates (Fig. 3b, c).
In accordance with mRNA levels we observed sig-
niﬁcantly reduced Gdnf protein levels in midbrain and
striatum samples from Gdnf heterozygous mice (Fig. 4a,
c, d, f). Moreover, we detected signiﬁcantly increased
Tgfb2 protein levels in striatum samples from Gdnf
heterozygous mice. Tgfb2 protein levels in midbrain
samples from these mice were slightly increased without
reaching signiﬁcance.
Morphology, distribution and number of TH-ir neurons
in SNpc of aged Tgfb2
?/-/Gdnf
?/- mice
For the analysis of the morphology of TH-immunoreactive
neurons in the SNpc, brains of aged wild type, Tgfb2 and
Gdnf single-heterozygous as well as Tgfb2/Gdnf double-
heterozygous animals were cut in 40-lm slices and stained
with anti-TH antibody. Figures 5a–d show that all geno-
types analyzed displayed a normal distribution of dopa-
minergic neurons in the SNpc. Detailed images (Fig. 5e–h)
show a normal cellular morphology of TH-ir neurons
indicating that haploinsufﬁciency for Tgfb2, Gdnf or Tgfb2
and Gdnf does not alter dopaminergic neuron distribution
and morphology in the SNpc of aged mice. Stereological
Fig. 2 Tgfb2 and Gdnf mRNA levels in heterozygous animals. a, b
Total RNA was isolated from striatal tissue of aged TGFb2 and Gdnf
animals and reverse transcribed. The levels of Tgfb2 (a) and Gdnf (b),
respectively, were signiﬁcantly reduced in heterozygous animals.
Three animals were used for each genotype. *P values derived from
student’s t test are\0.05
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123counting showed that aged Gdnf
?/- single-heterozygous
mice had slightly reduced numbers of TH-ir neurons in the
SNpc. However, this reduction in neuron number was not
signiﬁcant (Fig. 5i).
Striatal TH ﬁber density
DA neurons of the SNpc project to the dorsal striatum via
the nigrostriatal pathway. In order to analyze the density of
Fig. 3 Protein levels of Tgfb2
and Gdnf in Tgfb2
?/- mice.
Proteins were isolated from
midbrain and striatum samples
of 3-month-old Tgfb2
?/- mice
and wild-type littermates. After
electrophoresis and protein
transfer, membranes were
probed with anti-Tgfb2 and
anti-Gdnf antibodies. Gapdh
was used to determine equal
protein loading. Protein levels
of Tgfb2 were reduced in
midbrain (a, c) and striatum
samples (d, f)i nTgfb2
?/- mice.
Gdnf levels in the midbrains of
Tgfb2
?/- mice were similar to
wild-type littermates (b, c).
Interestingly, the protein levels
of Gdnf in striatum samples
were increased in Tgfb2
?/-
mice (e, f). Densitometric
analysis of protein band
intensities was performed using
FluorChem 8800 software
Fig. 4 Protein levels of Gdnf and Tgfb2i nGdnf
?/- mice. Proteins
were isolated from midbrain and striatum samples of 4.5-month-old
Gdnf
?/- mice and wild-type littermates. After electrophoresis and
protein transfer, membranes were probed with anti-Tgfb2 and anti-
Gdnf antibodies. Gapdh was used to determine equal protein loading.
Protein levels of Gdnf were signiﬁcantly reduced in midbrain (a, c)
and striatum samples (d, f) in Gdnf
?/- mice. Tgfb2 levels in the
midbrains of Gdnf
?/- mice were slightly increased compared to wild-
type littermates (b, c). Surprisingly, the protein levels of Tgfb2i n
striatum samples of Gdnf
?/- mice were signiﬁcantly increased
compared to wild-type littermates (e, f). Densitometric analysis of
protein band intensities was performed using FluorChem 8800
software. **,*P values derived from student’s t test are \0.05 and
\0.01
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123TH-positive nerve terminals in striata of aged mice, we
dissected the right forebrain (the left was used to isolate
striata for DA analysis). Figures 6a–d show the TH
immunohistochemistry results for the different genotypes
analyzed. There were no substantial differences in the
staining intensities of striatal slices of different genotypes.
Further, the analysis of the optical densities conﬁrmed
these impressions (Fig. 6e).
Normal striatal dopamine levels in aged
Tgfb2
?/-/Gdnf
?/- mice
As a functional readout for the nigrostriatal system we
analyzed the levels of dopamine (DA) and its metabolites
dihydroxyphenylacetic acid (DOPAC) and homovanillic
acid (HVA) in the striatum by HPLC. As shown in Fig. 7a,
therewerenosigniﬁcantdifferencesintheDAlevelsofaged
double-heterozygous and single-heterozygous animals
compared with age-matched wild-type mice. Further, the
levels of DOPAC and HVA (Fig. 7b, c), as well as the DA
turnover (data not shown) were not altered in aged mice in
all genotypes analyzed. These results indicate that haploin-
sufﬁciency for Tgfb2, Gdnf or Tgfb2 and Gdnf has no effect
on striatal DA synthesis and metabolism in aged animals.
Discussion
In the present study we analyzed the effect of double
haploinsufﬁciency for Tgfb2 and Gdnf on the maintenance
Fig. 5 Morphology,
distribution and number of TH-
positive neurons in the SNpc of
mutant animals. TH
immunohistochemistry of
midbrain sections from aged wt
(a), Tgfb2 single-heterozygous
(b), Gdnf single-heterozygous
(c) and Tgfb2/Gdnf double-
heterozygous mice (d) at low
magniﬁcation. Note that only
Gdnf single-heterozygous
animals show reduced numbers
of TH-positive midbrain
neurons. Scale bar for a–d
indicates 300 lm. Boxes mark
the areas used for generating
high magniﬁcation images (e–h)
that shown a normal
morphology and distribution of
TH-positive neurons in the
SNpc of aged animals. Again,
only the Gdnf single-
heterozygous show reduced
numbers of TH-positive
neurons. Scale bar for e–h
indicates 50 lm. i Stereological
cell counting of TH-positive
midbrain neurons. No
signiﬁcant differences exist
between the different genotypes
analyzed. However, the
numbers of TH-positive neurons
in SNpc of aged Gdnf single-
heterozygous animals is reduced
compared to wild-type animals.
Results are given as
mean ± SEM
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123of the nigrostriatal system in aged mice. Our results dem-
onstrate that aged Tgfb2
?/-/Gdnf
?/- mice had the same
numbers of TH-positive midbrain DA neurons as age-
matched wild-type animals. Further, there were no differ-
ences in the density of TH-positive ﬁbers in striata of
Tgfb2
?/-/Gdnf
?/- mice. As a functional readout for the
nigrostriatal system we analyzed the levels of dopamine
and its metabolites DOPAC and HVA in aged Tgfb2
?/-/
Gdnf
?/- mice. Again, we found no signiﬁcant differences
between double-haploinsufﬁcient and wild-type mice.
These data thus indicate that the combined haploinsufﬁ-
ciency for Tgfb2 and Gdnf has no effect on the morphology
and function of midbrain DA neurons under normal aging
conditions.
The observed lack of an age-dependent impairment of
morphology and function of midbrain DA neurons in Tgfb2
and Gdnf double haploinsufﬁciency was a highly unex-
pected.T g f b2 heterozygous animals were reported to have
a 12% reduction of DAergic neurons already at 6 weeks of
age, and striatal dopamine declined to 70% within
6 months (Andrews et al. 2006). This ﬁnding was not
reproduced in our study, as the aged Tgfb2
?/-/Gdnf
?/-
mice did not show a smaller number of TH-ir neurons in
the SNc or reduced striatal markers. Gdnf heterozygous
animals were documented to have an increasing age-
dependent reduction of the number of DA neurons, altered
ﬁber and cell body morphology, as well as reduced levels
of TH (Boger et al. 2006). In our study, the morphology of
DA neurons was normal. The mean number of TH-positive
neurons in the SNc was slightly smaller than controls, but
this difference did not reach statistical signiﬁcance
(Fig. 5i). Consistently, mice deﬁcient for RET receptor,
which forms the Gdnf receptor together with GDNF family
receptor a, have normal numbers of dopaminergic neurons
up to 12 months of age (Jain et al. 2006), and the same
sensitivity to MPTP as WT mice (Kowsky et al. 2007). The
RET receptor (and thus, likely Gdnf) were only required
for sprouting of axon collaterals in the striatum after MPTP
treatment (Kowsky et al. 2007), suggesting that Gdnf might
be more important for regeneration of dopaminergic neu-
rons than for survival per se. However, RET-deﬁcient mice
did show some loss of dopaminergic markers after
12 months of age (Kramer et al. 2007).
Taken together, our ﬁndings suggest that a reduction in
Tgfb2 and Gdnf mRNA and protein are not sufﬁcient to
affect the survival of dopaminergic neurons in the SNc in
aged (20–25 months old) mice. These ﬁndings are in line
with the normal dopaminergic system in Tgfb2
-/- Gdnf
-/-
embryos (Roussa et al. 2008). The discrepant ﬁndings by
others in ‘‘middle-aged’’ (12 months old) mice (Andrews
et al. 2006; Boger et al. 2006) might result from a stronger
depletion of Tgfb2 and Gdnf in these studies. Alternatively,
the normal, aging-related decline in dopamine neuron
numbers might arrive at a ‘‘ﬂoor’’ level at 20–25 months of
age, so that the difference between wild-type and hetero-
zygous animals is less pronounced than in ‘‘younger’’
animals.
Based on the previous ﬁndings by others, we had
expected that haploinsufﬁciency for both Tgfb2 and Gdnf,
would result in the same kind, or even in a more pro-
nounced age-dependent impairment of morphology and
function of DA neurons. The lacking phenotype of the
combined haploinsufﬁciency for both Tgfb2 and Gdnf
could be interpreted as a requirement for balanced levels of
both factors. Availability of both is required to promote
Fig. 6 TH immunohistochemistry of the striatum of wild type (a),
Tgfb2 single-heterozygous (b), Gdnf single-heterozygous (c) and
Tgfb2/Gdnf double-heterozygous mice (d) was normalized against
TH-staining of the cortex. Scale bar for a–d 1 mm. e Evaluation of
striatal ﬁber density. Results are given as mean ± SEM. No
signiﬁcant differences were observed between the different genotypes
analyzed
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123and maintain the survival of midbrain DA neurons. A
partial depletion of one of the factors may affect the bal-
ance of both proteins and might therefore result in an age-
dependent impairment of the system. Partial depletion of
both factors may then result in the establishment of a new
balance of the amounts of Tgfb2 and Gdnf, however, on a
lower level. Interestingly, we found that Gdnf protein
levels in striatal tissue from Tgfb2 heterozygous and Tgfb2
protein levels in striata from Gdnf heterozygous mice were
higher than in wild-type littermates. This phenomenon
could be interpreted as a compensatory mechanism after
partial depletion of one factor. Moreover, this hypothesis
would also support the fact that Gdnf and Tgfb2 cooperate
to promote and maintain the survival and status of differ-
entiation of midbrain DA neurons (Krieglstein et al. 1998;
Schober et al. 2007). A combined or balanced requirement
for Tgfb2 and Gdnf would have strong implications for
therapeutic strategies for PD patients based on Gdnf
administration.
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